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A B S T R A C T
Background: Left ventriculoplasty (LVP) and mitral valve plasty (MVP) are sometimes effective for
patients with idiopathic dilated cardiomyopathy (DCM) who are not eligible for heart transplantation.
Strict patient selection is warranted for these controversial procedures.
Methods and results: The subjects were 18 patients with idiopathic DCM and mitral regurgitation who
had not been indicated for heart transplantation due to either older age or patient refusal, and who
underwent LVP and MVP. Their mean age was 57  14 years and 50% were dependent on catecholamine
infusion. The preload recruitable stroke work (PRSW) relationship and its slope (Mw) were estimated by a
single-beat technique using transthoracic echocardiography. There were one 30-day mortality and six (33%)
hospital deaths due to heart failure. The one-year survival rate was 50%. Left ventricular end-diastolic
dimension (LVDd) decreased from 77  11 to 68  11 mm (p = 0.001) whereas the ejection fraction did not
change. Preoperative Mw was signiﬁcantly higher in one-year survivors than that in non-survivors
(54  17 erg cm3 103 vs. 31  10 erg cm3 103, p = 0.005). Preoperative LVDd was not different between the
groups. The cut-off value of 42 erg cm3 103 for Mw predicted one-year survival with high sensitivity (100%)
and speciﬁcity (77%).
Conclusions: Mw, the slope in the PRSW relationship, may predict survival after LVP and MVP in patients
with idiopathic DCM.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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The surgical strategy for patients with idiopathic dilated
cardiomyopathy (DCM) and severe mitral regurgitation (MR) is
controversial [1]. MR has a negative impact on the prognosis of
patients with heart failure and a very low ejection fraction [2,3].
Mitral valve plasty (MVP) for patients with secondary severe MR
and a low ejection fraction (<30%) is recommended in the
American Heart Association (AHA) guideline (class IIb) [4].
However, early recurrence of signiﬁcant MR and heart failure
symptoms within 6 months have been reported in patients with* Corresponding author at: Department of Cardiovascular and Thoracic Surgery,
Hokkaido University Graduate School of Medicine, Kita 14, Nishi 7, Kitaku, Sapporo
060-8648, Japan. Tel.: +81 11 716 1161x6041; fax: +81 11 706 7612.
E-mail address: ymatsui@med.hokudai.ac.jp (Y. Matsui).
http://dx.doi.org/10.1016/j.jjcc.2014.04.010
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsseverely dilated left ventricle (LV) after down-sized mitral
annuloplasty alone [5]. Thus, procedures in addition to mitral
annuloplasty appear to be necessary for the large LV.
To eliminate recurrence of MR and heart failure symptoms in
such high-risk patients, some groups, including ours, have
developed several submitral procedures such as left ventriculo-
plasty (LVP) and reported acceptable midterm results [6–15]. Thus
far, however, there exist no guidelines that recommend LVP
concomitant with MVP, and Batista-type LVP is even a class III
recommendation in the AHA guidelines [16]. We performed LV
plasty for extremely large heart in 55 cases from 2004 to 2013, and
one-year survival rate was 58%. From our experience, we believe
this operation has a role in selected patients. Although strict
patient selection is important for these controversial procedures,
we do not have any reliable LV functional parameters for the
prediction of responders to LVP and MVP that we can easily use in
clinical practice [17]. reserved.
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parameters would correlate with survival after operation. We
demonstrate here that preload recruitable stroke work relation-
ship is useful to predict survival after LVP and MVP in end-stage
heart failure patients with idiopathic DCM and severe MR.
Methods
Patients’ characteristics
Tables 1 and 2 show the patients’ preoperative characteristics.
The 23 consecutive cases included 18 idiopathic DCM patients with
end-stage heart failure who underwent LVP and MVP from 2006 to
2013 (mean age, 57  14 years; 27–77 years). Five patients were
excluded from the study due to lack of sufﬁcient echocardiographic
data. The diagnosis of DCM was based on the absence of signiﬁcant
coronary artery disease or primary valvular heart disease. The
pathological ﬁndings of the LV muscle specimens obtained during
surgery were also consistent with DCM in all cases. They all had NewTable 2
Preoperative characteristics in dilated cardiomyopathy patients.
Variables Total
(n = 18)
Age 57  14 
Male gender 15 (83%) 
Atrial ﬁbrillation 7 (39%) 
Diabetes mellitus 5 (28%) 
Renal dysfunction (serum creatinine >2.0 mg/dl) 5 (28%) 
NYHA class III/IV 10/8 
CRT-D implantation 7 (39%) 
Catecholamine dependent 9 (50%) 
Intra-aortic balloon pumping 2 (11%) 
Percutaneous cardiopulmonary support 1 (6%) 
Medications
Amiodarone 11 (61%) 
Beta blockers 16 (89%) 
Angiotensin-converting enzyme inhibitors 5 (28%) 
Angiotensin receptor blockers 7 (39%) 
Values  standard deviation. CRT-D, cardiac resynchronization therapy-deﬁbrillators; NY
Table 1
Patients’ clinical and echocardiographic characteristics of all 18 idiopathic dilated card
Age Gender NYHA class CA Dependent RF (Cr > 2.0) AF 
LVDd (m
One-year survivors
55 Male 3 Yes No Yes 88 
67 Male 4 Yes No Yes 73 
64 Male 3 No No No 80 
60 Female 3 No No Yes 82 
37 Male 3 No No No 69 
52 Male 3 No NO Yes 83 
63 Male 4 Yes No No 72 
36 Male 3 Yes No No 89 
27 Female 3 No No No 57 
Non-survivors
36 Male 4 Yes Yes No 94 
69 Male 3 No Yes No 72 
61 Male 4 Yes No No 88 
59 Male 4 Yes yes Yes 85 
55 Male 4 Yes No No 80 
67 Male 3 Yes No Yes 69 
71 Male 4 Yes Yes No 62 
77 Female 3 No Yes No 74 
64 Male 3 No No Yes 73 
AF, atrial ﬁbrillation; CA, catecholamine; DcT, deceleration time; NYHA, New York Hear
end-systolic dimension; LVEF, left ventricular ejection fraction; MR, mitral regurgita
applicable; RF, renal failure.York Heart Association (NYHA) class III or IV. Nine (50%) patients were
dependent on catecholamine infusion just before operation. Intra-
aortic balloon pumping in two patients and percutaneous cardiopul-
monary support in one patient were needed just before the operation
due to hemodynamic instability. While most patients used beta-
blockers preoperatively, the use of angiotensin-converting enzyme
inhibitors and angiotensin receptor blockers was relatively rare due
to the low blood pressure and renal dysfunction. None of the patients
had been registered for heart transplantation due to their age being
over 60 years, which was the limited age in Japan at that time, in
11 cases and the patients’ refusal in 7 cases. The University Ethics
Committee approved the research protocol and informed consent was
obtained from the subjects.
Surgical procedures
To reshape the severely remodeled LV, we performed over-
lapping LVP without a patch as previously reported [10]. Brieﬂy, we



















HA, New York Heart Association.
iomyopathy cases.
Echocardiographic data
m) LVDs (mm) LVEF (%) DcT (ms) MR grade Mw (erg cm3103)
81 34 135 4 56
68 23 136 4 28
70 24 144 4 46
67 33 212 4 59
54 31 231 4 43
79 21 125 4 41
66 28 350 4 67
76 40 244 4 88
52 31 108 4 59
87 10 100 3 21
69 21 130 4 41
85 17 82 4 17
74 32 NA 4 44
74 24 115 4 33
59 23 150 4 33
58 14 120 4 18
69 21 158 4 31
70 27 96 3 37
t Association; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular
tion; Mw, the slope in the preload recruitable stroke work relationship; NA, not
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was sutured continuously on the deep septal wall using 3-0
polypropylene sutures with specially designed large curved
needles. After aortic declamping, the medial wall was then
overlapped on the lateral wall using interrupted 4-0 polypropylene
sutures. When myocardial ﬁbrosis was evident only in the
posterior part of the LV, we employed a Batista-type operation.
We performed MVP as a part of our original mitral complex
reconstruction [14]. Brieﬂy, papillary muscle approximation is a
surgical method to join the entire papillary muscles side-by-side
from the bases to the heads by three pledgeted mattress sutures of
3-0 polypropylene. We placed a subvalvular CV-4 ePTFE suture
between the site of the chordal attachment of the approximated
papillary muscles and the anterior mitral annulus. This suture was
passed through the true-sized semi-rigid total annuloplasty ring
[14].
Assessment of cardiac function by echocardiography
We used a Sonos 5500 ultrasound system (Philips Medical
Systems, Andover, MA, USA) with a 3S transducer (3–5 MHz), a
Vivid Seven system (GE/Vingmed, Milwaukee, WI, USA) with an
M3S (2.5–3.5 MHz) transducer, or an Aplio system (Toshiba
Medical Systems, Tokyo, Japan) with a 2.5 MHz transducer. These
instruments were operated by experienced examiners who were
blinded for the study. The following basic variables were measured
from the parasternal long-axis view: LV end-diastolic (LVDd) and
end-systolic dimensions (LVDs) (mm), left atrial dimension (LAD)
(mm), interventricular septal thickness (IVST), and LV posterior
wall thickness (LVPWT) (mm). On an apical long-axis image, the
pulsed Doppler sample volume was located at the tip of the mitral
valve leaﬂets to obtain the deceleration time (DcT) (ms) of the early
transmitral ﬂow velocity. The LV end-diastolic volume (EDV), end-
systolic volume (ESV), and LV ejection fraction (LVEF) were
measured using the modiﬁed Simpson method. The MR grade was
determined by the proximal isovelocity surface area method or
color Doppler images. In four cases, echocardiography was
performed under dobutamine infusion (4–5 mg/kg/min). These
four cases were not excluded because of very low Mw even with
dobutamine. All values were averaged using three consecutive
measurements.
Estimation of preload recruitable stroke work relationship
Stroke work in the heart with MR was calculated as we
previously reported: (total stroke volume)  (SBP  LAP)
(ml mmHg), where SBP and LAP indicate systolic blood pressure
and left atrial pressure, respectively [18]. Total stroke volume was
calculated using the time velocity integral of pulsed Doppler at the
LV outﬂow tract and mitral annulus level as follows: (forward
stroke volume) + (regurgitation volume) (ml). LAP was estimated
by continuous wave Doppler of the MR jet as follows: (systolic
blood pressure)  (peak pressure gradient of the wave) (mmHg)
[19].
The preload recruitable stroke work (PRSW) relationship and its
slope (Mw), which is recognized as a load-insensitive index of
contractile function, were estimated by a single-beat technique
according to a report by Lee et al. [20]. Brieﬂy, ‘‘Mw’’ was calculated
as follows: (total stroke work)/[EDV  k  EDV + (1  k)  LV wall]
(erg cm3 103). EDV was derived from the total stroke volume and
LVEF. LV wall was estimated by the echocardiography-derived LV
mass. Constant k was estimated by an equation: k = 0.0004  LV
mass + 0.6408. This single-beat technique for Mw has been
reported to be well correlated to that by the invasive catheter
method for different LV sizes, LV mass, and the presence of regional
wall motion abnormalities [20].Validation of total stroke work by echocardiography alone using MR
model in rat
To validate the key non-invasive parameter of total stroke work,
we performed a pilot experiment using two male Sprague–Dawley
rats (body weight, 300 g) obtained from Sankyo Labo Service
Corporation (Tokyo, Japan). The use of animals was in accordance
with the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH publication
no. 85–23, revised 1996) and the experimental protocols were
approved by the local Animal Welfare Committee of the Hokkaido
University, Japan. MR was created by damaging the mitral valve
using 24G needles as previously reported [21]. Severe MR was
conﬁrmed by color Doppler. Four weeks after the procedure,
animals were anesthetized with intramuscular ketamine and
xylazine injection (45 and 4.5 mg/kg, respectively). The rats were
examined in supine position by a Sonos 5500 ultrasound system
with a 12-MHz phased array transducer and a 1.4F Millar catheter
inserted through the right carotid artery and advanced into the LV.
Signals of LV pressure and volume assessed by acoustic quantiﬁ-
cation mode in standard apical four-chamber view were simulta-
neously displayed in real-time mode in the monitor of the
computer using a multichannel 16-bit analog-to-digital converter
(PowerLab, ADInstruments, Sydney, Australia) and a data acquisi-
tion software (LabChart, ADInstruments). External total stroke
work was automatically measured from the area of pressure–
volume loops (TSW-loop) in the software at baseline and after
bolus saline infusion of 2, 4, 6, 8, and 10 ml. The values from 10
consecutive cycles were averaged at each volume loading. At each
loading condition, total stroke work by echocardiography alone
(TSW-echo) was separately measured by the formula, (total stroke
volume)  (SBP  LAP) (ml mmHg), based on an assumption that
pressure–volume loop is a square. These two different methods,
TSW-loop and TSW-echo, were compared at each loading
condition.
Statistical analysis
All the data are given as mean  standard deviation. Statistical
analysis was performed with SPSS version 17.0 software (SPSS Inc.,
Chicago, IL, USA). Categorical data were compared by Fisher’s exact
test. The Mann–Whitney U-test was used to compare the continuous
variables between the groups and the Wilcoxon test to compare the
preoperative and postoperative values. The receiver operating
characteristic (ROC) curve was used to analyze the sensitivity and
speciﬁcity of the parameters for detecting one-year survival. We
selected the cut-off values that maximize sensitivity plus speciﬁcity.
The area under the curve (AUC) was used to compare predictive
parameters. The survival rate was analyzed by the Kaplan–Meier
method and log-rank test. In the animal study, the Bland–Altman test
was used to assess the limits of agreement and conﬁdence intervals
between the two methods, TSW-loop and TSW-echo. A p-value < 0.05
was considered statistically signiﬁcant.
Results
Pilot experimental data
Mean total stroke work of different volume loading conditions
was 8.6  3.2 ml mmHg and 9.8  4.6 ml mmHg by TSW-echo and
TSW-loop, respectively. Linear regression analysis demonstrated a
signiﬁcant correlation between the two methods: y = 1.28x  1.25,
r = 0.898, p < 0.001. Fig. 1A shows representative consecutive 10
cycles of pressure–volume loop. Fig. 1B shows the Bland–Altman
spots which also indicated good correlation between the two methods,
with only one of the 14 measurements being over 1.96 SD.
Fig. 1. (A) Representative consecutive 10 cycles of pressure–volume loop (TSW-loop) and an assumed square for TSW-echo (dashed line). (B) Bland–Altman spots to assess the
limits of agreement and conﬁdence intervals between the two methods, TSW-loop and TSW-echo. MR, mitral regurgitation; TSW, total stroke work.
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is assumed to be a square (Fig. 1A, dashed line) would be approximated
to TSW-loop. We used TSW-echo for the calculation of Mw formula,
TSW/[EDV  k  EDV + (1  k)  LV wall], proposed by Lee et al. in
which constant k was derived from human clinical data [20].
Operative data
All patients underwent mitral complex reconstruction includ-
ing mitral annuloplasty and papillary muscle approximation as a
part of LVP. There was no conversion to mitral valve replacement.
Thirteen (72%) patients underwent LVP by overlapping and two
patients (11%) by a Batista-type procedure. Tricuspid valve ring
annuloplasy was performed in all cases and the MAZE procedure
was conducted in ﬁve (28%). Cardiopulmonary bypass and aortic
cross clamp times were 235  61 min and 114  24 min, respec-
tively.Table 3




Heart rate, bpm 73  14 
Systolic blood pressure, mmHg 88  10 
Diastolic blood pressure, mmHg 53  10 
BNP, pg/ml 1346  1041 1
Cardiac catheter data
Cardiac index, L/min/m2 2.0  0.4 
sPA, mmHg 48  17 
PCWP, mmHg 23  10 
Echocardiographic data
LVDd, mm 77  10 
LVDs, mm 70  10 
IVST, mm 9.3  1.0 
LVPWT, mm 8.4  1.2 
LVEF, % 25  8 
LAD, mm 57  12 
DcT, ms 155  68 
MR grade 3.9  0.3 
Regurgitation volume, ml 49  21 
Forward stroke volume, ml 43  20 
Estimated LAP, mmHg 24  14 
LVEDV, ml 291  105 
LVESV, ml 218  91 
Values  standard deviation. BNP, brain natriuretic peptide; DcT, deceleration time; IVST,
LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dime
fraction; LVESV, left ventricular end-systolic volume; LVPWT, left ventricular posterior w
sPA, systolic pulmonary artery pressure.Comparison between one-year-survivor and non-survivor groups
There was one (6%) operative mortality within 30 days. There
were six (33%) hospital deaths due to heart failure. The overall
survival rates were 61% after 6 months and 50% 1 year after
operation (one-year survivors, n = 9; non-survivors, n = 9).
Table 2 shows the differences in patients’ preoperative
characteristics between the one-year-survivor and non-survivor
groups. Renal dysfunction (serum creatinine >2.0 mg/dl) was
more common in non-survivors than in one-year survivors. Age
and preoperative medication were comparable between the
groups.
Table 3 shows the differences in preoperative cardiac functional
parameters between one-year survivors and non-survivors. In one-
year survivors, the heart rate was signiﬁcantly lower and DcT was
signiﬁcantly longer, which indicate lower LV ﬁlling pressure than





67  11 79  15 0.042
88  11 89  10 0.76
50  9 56  10 0.12
066  716 1628  1271 0.35
2.1  0.5 1.9  0.3 0.32
40  18 55  14 0.07
22  12 26  8 0.86
77  10 77  10 1.00
68  10 72  10 0.43
9.7  0.9 9.0  1.1 0.14
8.4  1.2 8.3  1.2 0.85
29  6 21  7 0.019
58  12 57  12 0.70
187  79 119  26 0.034
4.0  0.0 3.8  0.4 0.15
61  20 34  11 0.011
53  23 33  12 0.040
18  7 30  17 0.11
285  82 297  129 0.97
197  57 238  116 0.83
 interventricular septal thickness; LAD, left atrial dimension; LAP, left atrial pressure;
nsion; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection
all thickness; MR, mitral regurgitation; PCWP, pulmonary capillary wedge pressure;
Table 4
Changes in cardiac functional parameters in dilated cardiomyopathy patients.
Variables Total (n = 15) One-year survivors (n = 9) Non-survivors (n = 6)
PreOP PostOP PreOP PostOP PreOP PostOP
Heart rate, bpm 74  15 84  13* 67  11 80  13* 83  14# 90  12
SBP, mmHg 89  11 87  10 88  11 89  6 90  12 83  14
DBP, mmHg 53  10 55  7 50  9 57  4 58  11 53  10
Echocardiography
LVDd, mm 77  11 68  11** 77  10 67  9** 77  12 69  10*
LVDs, mm 69  11 61  9** 68  10 59  7** 71  12 64  10*
LVEF, % 25  8 23  5 29  6 26  4 18  5## 19  5##
MR grade 3.9  0.3 0.4  0.5** 4.0  0.0 0.2  0.4** 3.8  0.5 0.5  0.5*
Forward stroke volume, ml 43  21 47  17 53  23 57  15 30  8# 35  12#
SPECT
LVEDV, ml 351  118 243  81** 361  80 250  71* 337  170 231  102*
LVESV, ml 271  118 188  74** 265  62 182  49* 292  183 198  115
Reduction rate (LVEDV), % – 29  13 – 34  14 – 23  8
Reduction rate (LVESV), % – 28  16 – 33  17 – 20  13
Values  standard deviation. DBP, diastolic blood pressure; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; LVEDV, left ventricular
end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; MR, mitral regurgitation; OP, operation; SBP, systolic blood pressure;
SPECT, single photon emission computed tomography. *p < 0.05 and **p < 0.01 vs. preOP values; #p < 0.05 and ##p < 0.01 vs. one-year survivors.
Fig. 3. Survival curves by Kaplan–Meier analysis in those with higher Mw
(42 erg cm3 103) and lower Mw (<42 erg cm3 103). LVP, left ventriculoplasty;
MVP, mitral valve plasty; Mw, the slope in preload recruitable stroke work
relationship.
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survivors than in non-survivors. LVDd and LV volumes were not
signiﬁcantly different between the groups.
Table 4 shows changes in cardiac functional parameters in one-
year-survivor and non-survivor groups. The postoperative echo-
cardiographic parameters were not applicable due to poor
recording in three cases. The postoperative MR grade was mild
or less in all cases. There was no reoperation due to recurrent
MR during the follow-up (median, 11 months). In total, LVDd
signiﬁcantly decreased from 77  11 mm to 68  11 mm
(p = 0.001), although LVEF did not signiﬁcantly change even with
the elimination of signiﬁcant MR (from 25  8% to 23  5%, p = 0.51),
possibly because of concomitant LV volume reduction surgery. LVEF
and forward stroke volume were signiﬁcantly smaller in the non-
survivor than in the one-year-survivor group both before and after
surgery. LVESV did not signiﬁcantly decrease after surgery and
reduction rates were relatively low in the non-survivor group even
though there was no statistical signiﬁcance.
Fig. 2 shows preoperative Mw in PRSW, a load-insensitive index
of contractile function in the one-year-survivor and non-survivor
groups. Mw was signiﬁcantly higher in one-year survivors than in
non-survivors (54  17 erg cm3 103 vs. 31  10 erg cm3 103,
p = 0.005).Fig. 2. Preoperative Mw, the slope in the preload recruitable stroke work
relationship, which is a load-insensitive index of contractile function, in one-year
survivors and non-survivors who underwent left ventriculoplasty and mitral valve
plasty.In the ROC curve analysis for prediction of one-year survival
after surgery, AUCs were 0.982 (p = 0.002), 0.929 (p = 0.005), 0.884
(p = 0.013), and 0.804 (p = 0.049) for preoperative Mw, LVEF, MR
volume, and deceleration time, respectively. The preoperative Mw
was the best parameter to predict one-year survival after surgery.
Mw-cut-off value of 42 erg cm3 103 predicted one-year survival
with sensitivity and speciﬁcity of 100% and 77%, respectively.
Fig. 3 shows survival curves determined by Kaplan–Meier
analysis in those with ‘‘higher Mw’’ (42 erg cm3 103, n = 8) and
‘‘lower Mw’’ (<42 erg cm3 103, n = 10). The patients with higher
Mw tended to have a better survival rate than those with lower Mw
(log-rank p = 0.005). All but one patient with higher Mw survived
with NYHA class of less than II (maximum survival, 5 years after
surgery). On the other hand, in the group with lower Mw, more
than half of the patients died of heart failure within 6 months after
operation. There was no difference in preoperative characteristics
except for LVEF in the higher and lower Mw group (Table 5).
Discussion
We demonstrated that preoperative Mw, a load-insensitive
index of contractile function, was a good predictor of one-year
Table 5
Preoperative characteristics of patients with higher and lower Mw.





Age 50  14 62  12 0.06
Male gender 6 9 0.56
Atrial ﬁbrillation 3 4 1.00
Diabetes mellitus 2 3 1.00
Renal dysfunction (serum creatinine >2.0 mg/dl) 1 4 0.31
NYHA class III/IV 5/3 5/5 0.66
CRT-D implantation 1 6 0.05
Catecholamine dependent 3 6 0.64
Intra-aortic balloon pumping 1 1 1.00
Percutaneous cardiopulmonary support 1 0 0.44
Medications
Amiodarone 6 5 0.37
Beta blockers 6 10 0.18
Angiotensin-converting enzyme inhibitors 1 4 0.31
Angiotensin receptor blockers 4 3 0.63
Echocardiographic data
LVDd, mm 78  11 77  9 0.83
LVDs, mm 68  10 72  10 0.46
LVEF, % 32  5 20  5 <0.001
Values  standard deviation. CRT-D, cardiac resynchronization therapy-deﬁbrillators; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic
dimension; LVEF, left ventricular ejection fraction; Mw, the slope in preload recruitable stroke work relationship; NYHA, New York Heart Association.
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MR, whereas LV size was not. This preliminary study will
contribute to the decision-making for the indication and timing
of LVP and MVP for patients with end-stage heart failure who are
not eligible for heart transplantation.
Some groups, including ours, have been trying to develop
submitral procedures and LVP in order to eliminate recurrence of
MR and heart failure symptoms in high-risk patients [6–15]. A
group from the Cleveland clinic reported midterm results of mitral
valve surgery and LV volume reduction surgery (Batista operation)
for patients with idiopathic DCM and end-stage heart failure [6].
The early mortality was 4% and one-year survival was 82%. They
suggested that older age (>40 years) was the only predictive
parameter for mortality, and that other functional parameters,
including LV size and LVEF, did not correlate with survival after
surgery. Suma et al. reported midterm results of mitral valve
surgery in combination with selected LVP (Batista or septal
anterior ventricular exclusion) for 95 patients with idiopathic DCM
[22]. The three-year survival rates were 37% and 74% in patients
with and without inotropic support before surgery, respectively.
They suggested that preoperative inotropic dependency was the
only contributing factor for mortality. Nonetheless, they did not
ﬁnd any cardiac functional parameters that predicted survival after
operation. Thus far, therefore, there is no reliable functional
parameter that we can easily assess in daily clinical practice to
predict survival after LVP and MVP. In addition, there exists no
demonstrable surgical strategy for patients with end-stage heart
failure and signiﬁcant MR.
The PRSW relationship and its slope, Mw, were estimated by a
single-beat technique according to a report by Lee et al. [20]. This
single-beat technique for Mw has been reported to be correlated
well with that by the invasive catheter method for different LV
sizes, LV mass, and the presence of regional wall motion
abnormalities. A ﬂat slope, low Mw, indicates that increased
preload produces relatively little increase in stroke work because
of reduced contractility. The relationship takes both preload and
afterload into account and is applicable in a wide variety of cardiac
diseases. In the current study, the preoperative Mw was the best
parameter to predict one-year survival after surgery. Although
LVEF was also a good parameter, we consider that PRSW would be
more suitable for predicting prognosis of patients than LVEFbecause PRSW considers LV developed pressure as well as stroke
volume, which would reﬂect intrinsic LV capacity to pump.
Although we need more evidence of efﬁcacy in these preliminary
procedures, we might consider LVP and MVP for idiopathic DCM
patients with refractory heart failure before assist device
implantation or heart transplantation when their Mw is greater
than 42 erg cm3 103.
In this calculation of Mw, we need to determine the total stroke
work in the heart with MR. We recently reported a noninvasive
method for the estimation of total stroke work using transthoracic
echocardiography, which is based on an assumption that the LV
pressure–volume loop is approximated to a square [18].
Total stroke work was calculated as follows: total stroke
work = (forward stroke volume + MR volume)  (LVSP  LVDP),
which was further approximated to ‘‘(forward stroke volume + MR
volume)  (SBP  LAP)’’, where LVSP and LVDP indicate LV systolic
and diastolic pressure, respectively. This formula is different from
that reported by Chow et al. [23]: (forward stroke volu-
me  SBP) + (MR volume  LAP). It is conceivable that regurgitant
stroke work in MR should be calculated using LV pressure, but not
LAP, as LV stroke work is always derived from ‘‘LV’’ pressure. In
aortic valve stenosis, for example, we estimate LV stroke work from
stroke volume multiplied by higher ‘‘LV’’ pressure, but not lower
‘‘aortic’’ pressure. Furthermore, we do not need the values of aortic
and MR impedances for estimating LV stroke work. Aortic and MR
impedances directly inﬂuence the forward and backward stroke
volumes, respectively. The effect of different impedance is
included in LV stroke work which is derived from LV stroke
volumes.
Limitations
The major limitation of this study is the small number of
subjects. Second, the results in the current study are applicable
only for MVP concomitant with LVP. Further study is necessary to
examine the usefulness of Mw in PRSW for isolated MVP. Third,
this study does not answer the question of whether volume
reduction surgery in addition to MVP has any beneﬁcial effect on
LV function and such a surgery improves survival and functional
status. A randomized trial with more subjects is necessary to
determine this.
Y. Shingu et al. / Journal of Cardiology 65 (2015) 157–163 163Conclusions
Mw, the slope in the preload recruitable stroke work relation-
ship, may predict survival after LVP and MVP in patients with
idiopathic DCM and refractory end-stage heart failure, although
further studies are necessary to validate its use.
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